ixazomib,lenalidomide
takeda
['gem2014main']
outstanding data presented by highlighting the use of qip-mas in the evaluation of mrd in the gem2014main trial. qip-mas has similar prognostic value as ngf and can be performed in peripheral blood. #ash2022 
Hematologist working at the Clínica Universidad de Navarra, focused on multiple myeloma.